Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes

The treatment of acute coronary syndrome (ACS) in elderly patients continues to be a challenge because of the characteS.G.B.ristics of this population and the lack of data and specific recommendations. This review summarizes the current evidence about critical points of oral antithrombotic therapy i...

Full description

Bibliographic Details
Authors: Bonanad, Clara, Esteve Claramunt, Francisca, García Blas, Sergio, Ayesta, Ana, Díez Villanueva, Pablo, Pérez Rivera, Jose Ángel, Ferreiro, José Luis, Cánoves, Joaquim, López Fornás, Francisco, Ariza Solé, Albert, Raposerias, Sergio, Vivas, David, Blanco, Regina, Bompart Berroterán, Daznia, Cordero, Alberto, Núñez, Julio, Fácila, Lorenzo, Núñez Gil, Iván, Górriz, José Luis, Bodi, Vicente, Martínez Selles, Manuel, Ruiz Nodar, Juan Miguel, Chorro, Francisco Javier
Format: article
Status:Published version
Publication Date:2022
Country:España
Institution:Universidad de Barcelona
Repository:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/187068
Online Access:https://hdl.handle.net/2445/187068
Access Level:Open access
Keyword:Malalties del cor
Anticoagulants (Medicina)
Heart diseases
Anticoagulants (Medicine)
Description
Summary:The treatment of acute coronary syndrome (ACS) in elderly patients continues to be a challenge because of the characteS.G.B.ristics of this population and the lack of data and specific recommendations. This review summarizes the current evidence about critical points of oral antithrombotic therapy in elderly patients. To this end, we discuss the peculiarities and differences reported referring to dual antiplatelet therapy (DAPT) in ACS management in elderly patients and what might be the best option considering these population characteristics. Furthermore, we analyze antithrombotic strategies in patients with atrial fibrillation (AF), with a particular focus on those cases that also present coronary artery disease (CAD). It is imperative to deepen our knowledge regarding the management of these challenging patients through real-world data and specifically designed geriatric studies to help resolve the questions remaining in their disease management.

Similar Items